It has thus been proposed that up‐regulation of ZNF521 in rare leukemia initiating cells may facilitate tumor progression, even though ZNF521 over‐expression is not detected in the majority of leukaemic B‐cells from patients (Mesuraca et al., 2015). The gene discussed is ZNF521; the disease is leukemia.